Literature DB >> 8417385

Head and neck cancer.

E E Vokes1, R R Weichselbaum, S M Lippman, W K Hong.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8417385     DOI： 10.1056/NEJM199301213280306

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  316 in total

1.  Detection of residual disease of lymph node metastases in the neck, which is treated by (chemo)radiation.

Authors:  J A Castelijns; C R Leemans
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

Review 2.  Chemopreventive potential of natural compounds in head and neck cancer.

Authors:  Mohammad Aminur Rahman; A R M Ruhul Amin; Dong M Shin
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

3.  Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma.

Authors:  A Chahlavi; T Todo; R L Martuza; S D Rabkin
Journal:  Neoplasia       Date:  1999-06       Impact factor: 5.715

4.  Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer.

Authors:  M A List; P Mumby; D Haraf; A Siston; R Mick; E MacCracken; E Vokes
Journal:  Qual Life Res       Date:  1997-04       Impact factor: 4.147

Review 5.  Economic burden of head and neck cancer. A literature review.

Authors:  Jennifer M Lee; Marco Turini; Marc F Botteman; Jennifer M Stephens; Chris L Pashos
Journal:  Eur J Health Econ       Date:  2004-02

6.  Downregulation of SMG-1 in HPV-positive head and neck squamous cell carcinoma due to promoter hypermethylation correlates with improved survival.

Authors:  Evgenia Gubanova; Brandee Brown; Sergei V Ivanov; Thomas Helleday; Gordon B Mills; Wendell G Yarbrough; Natalia Issaeva
Journal:  Clin Cancer Res       Date:  2012-01-13       Impact factor: 12.531

7.  Randomized trial of 13-cis retinoic acid compared with retinyl palmitate with or without beta-carotene in oral premalignancy.

Authors:  Vassiliki A Papadimitrakopoulou; J Jack Lee; William N William; Jack W Martin; Margaret Thomas; Edward S Kim; Fadlo R Khuri; Dong M Shin; Lei Feng; Waun Ki Hong; Scott M Lippman
Journal:  J Clin Oncol       Date:  2008-12-15       Impact factor: 44.544

8.  Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck.

Authors:  M S Kies; D Grinblatt; M Runge-Morris; R Blough; A Watkins; S Taylor
Journal:  Invest New Drugs       Date:  1994       Impact factor: 3.850

9.  An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

Authors:  Charles M Rudin; Ezra E W Cohen; Vassiliki A Papadimitrakopoulou; Sol Silverman; Wendy Recant; Adel K El-Naggar; Kirsten Stenson; Scott M Lippman; Waun Ki Hong; Everett E Vokes
Journal:  J Clin Oncol       Date:  2003-11-03       Impact factor: 44.544

10.  Relationship of tobacco smoking with GSTM1 gene polymorphism in laringeal cancer.

Authors:  F Bardakci; E Canbay; Naci Degerli; L Coban; E I Canbay
Journal:  J Cell Mol Med       Date:  2003 Jul-Sep       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.